Skip Navigation
Header Logo

Schedule highlights

  • Networking

    Nov 15 02:00PM–02:15PM UTC

    Event Open and Networking

    Network with the wider community and industry experts across Cell & Gene Therapy with our Speed Networking event.

  • Stage

    Nov 15 02:15PM–02:20PM UTC

    Opening and Welcome to The Cell and Gene Therapy Forum

    Opening and Welcome from our host:

    Kris Wronski, Cell Culture Applications Scientist, EMEA Cell Culture, Thermo Fisher Scientific

  • Stage

    Nov 15 02:20PM–02:50PM UTC

    Landscape of Cell and Gene Therapies ​

    Mohan Vemuri, Director, R&D Cell & Gene Therapy, Cell Biology, Thermo Fisher Scientific


  • Stage

    Nov 15 02:50PM–03:05PM UTC

    Simplification of T cell Manufacturing Using The G-Rex® Platform as a First Step Towards Automation

    Anastasiya Smith, Director of Research and Development, Marker Therapeutics, Inc

  • Stage

    Nov 15 03:05PM–03:30PM UTC

    CAR T CELLS: Addressing the manufacturing challenges

    Stefano Iacovelli, PhD, Production Manager GMP Biopharmaceutical Facility

  • Stage

    Nov 15 03:30PM–04:00PM UTC

    A practical approach for GMP-complaint ​validation of real time PCR Method for Mycoplasma detection in advanced therapy medicinal productions

    Valentina Becherucci, Quality Control Laboratory , Cell Factory Meyer​, Meyer Children’s Hospital

  • Stage

    Nov 15 04:00PM–04:20PM UTC

    Strategic partnering to enable cell therapy commercialization

    Jenessa Smith, Director Process Development, ArsenalBio


  • Break

    Nov 15 04:20PM–04:35PM UTC

    Break

  • Stage

    Nov 15 04:35PM–05:00PM UTC

    Organoids and 3D-models in modern Oncology: Challenges and Chances

    Dr. Yazid J. Resheq, Clinician Scientist/Oncologist - Medical Dept. I (GI-Oncology)- University of Ulm

  • Stage

    Nov 15 05:00PM–05:20PM UTC

    Upstream Manufacturing Process Development of Recombinant AAV Vectors for Enhanced Capsid Integrity

    Helena Meyer-Berg, Ph.D., AAV Platform Manager, SIRION Biotech

  • Stage

    Nov 15 05:20PM–05:45PM UTC

    Bringing Viral Vector Manufacturing and Analytics to the Global Gene Therapy Community​

    Florian Leseigneur, Head of DSP, DiNAQOR


  • Stage

    Nov 15 05:45PM–06:15PM UTC

    QuantStudio™ Absolute Q™ Digital PCR System & Viral Titer Digital PCR Assays

    David Joun, Molecular Biology Scientist in R&D, Thermofisher Scientific

    Unnati Dev, Product Manager, Pharma Analytics, Thermo Fisher Scientific

  • Stage

    Nov 15 06:15PM–07:00PM UTC

    Addressing Genetic Stability for Stem Cell Derived Products

    Amanda Mack, PhD, Principal, Dark Horse Consulting Group

Speakers

Kris Wronski

Kris Wronski

Cell Culture Applications Scientist, EMEA Cell Culture, Thermo Fisher Scientific

Valentina Becherucci

Valentina Becherucci

Quality Control Laboratory ​Cell Factory Meyer​ Meyer Children’s Hospital, Florence Italy​

Dr Yazid Resheq

Dr Yazid Resheq

Clinician Scientist, Facharzt für Innere Medizin und Hämatologie und Onkologie

Florian Leseigneur

Florian Leseigneur

Head of DSP, DiNAQOR

Anastasiya Smith PhD

Anastasiya Smith PhD

Director of Research and Development, Marker Therapeutics, Inc

David James

David James

CEO, Scinogy Pty Ltd

Helena Meyer-Berg

Helena Meyer-Berg

Helena Meyer-Berg, Ph.D. AAV Platform Manager, SIRION Biotech

Jenessa Smith

Jenessa Smith

Director Process Development, ArsenalBio

Pablo Mancheño Corvo

Pablo Mancheño Corvo

Senior Scientific, Takeda Madrid, Cell Therapy Technology Center

Rupa Pike

Rupa Pike

Sr. Director, Technical Affairs- Advanced Therapies Pharma Services, Thermo Fisher Scientific

Evan Zynda

Evan Zynda

Senior Staff Scientist, Cell Biology Thermo Fisher Scientific

Mohan Vemuri

Mohan Vemuri

Director, R&D Cell & Gene Therapy, Cell Biology, Thermo Fisher Scientific

Oystein Amellem PhD

Oystein Amellem PhD

Director, Cell Therapy​, Thermo Fisher Scientific

David Joun

David Joun

Molecular Biology Scientist in R&D, Thermofisher Scientific

David Kuninger

David Kuninger

Director, R&D, Thermo Fisher Scientific

Stefano Iacovelli, PhD

Stefano Iacovelli, PhD

Production Manager GMP Biopharmaceutical Facility

Erica Heipertz

Erica Heipertz

Staff Scientist, Thermo Fisher Scientific

Amanda Mack

Amanda Mack

PhD, Principal, Dark Horse Consulting

Odette Becheau

Odette Becheau

Application Scientist, TreeFrog Therapeutics

Dr. Panteli Theocharous FIBMS, MS, PhD, FRCPath

Dr. Panteli Theocharous FIBMS, MS, PhD, FRCPath

Global Vice President Cell and Gene Therapy Strategy Lead Clinical Research, PPD, part of Thermo Fisher Scientific